Crisis Support
Trevor Project: 1-866-488-7386
Trans Lifeline: 877-565-8860
Crisis Text Line: Text START to 678-678

STIs: Types, Testing,
and Treatment

Clear, factual, shame-free information on the most common sexually transmitted infections. Getting tested, knowing what to do if you test positive, and staying healthy are acts of self-care.

STIs Testing Treatment
This page is educational, based on CDC and WHO guidelines. It is not a substitute for medical advice. If you have symptoms or think you may have been exposed to an STI, see a healthcare provider or visit a sexual health clinic.
2.5M New chlamydia cases in U.S. annually
CDC, 2022
70% Of STIs show no symptoms
WHO, 2023
3-8x HIV risk increase with active STI
CDC STI-HIV Interaction
Free Testing available nationwide at clinics
HRSA / CDC

The most important thing to know about STIs: most have no symptoms. You can have gonorrhea, chlamydia, or syphilis and feel completely fine while unknowingly passing them to partners. This is why regular testing is the foundation of sexual health for everyone who is sexually active, not just if you feel sick.

STIs and HIV: The Critical Connection

Active STIs significantly increase both the risk of transmitting HIV and the risk of acquiring HIV from an exposure. Gonorrhea and syphilis can increase HIV transmission risk by 3 to 8 times per sexual act. This is because STIs cause inflammation, ulcers, and tissue damage that both increase viral shedding and create entry points for HIV. Regular STI testing and prompt treatment is one of the most effective HIV prevention strategies available.

Common STIs: Symptoms, Testing, and Treatment

Gonorrhea Curable

Bacterial Infection (Neisseria gonorrhoeae)

Symptoms

  • Often none (especially rectal and throat infections)
  • Penile: discharge (yellow, green, white), burning urination
  • Vaginal/cervical: increased discharge, pelvic pain, spotting
  • Rectal: discharge, pain, bleeding
  • Throat: usually asymptomatic, rarely sore throat

Testing

  • Urine sample (urogenital)
  • Swabs from throat, rectum, or urethra
  • NAAT test (nucleic acid amplification) is most accurate
  • Test all sites of sexual contact, not just urine
  • Recommended every 3 months for sexually active MSM

Treatment

  • Single dose ceftriaxone injection (IM) is first-line treatment
  • Oral alternatives for uncomplicated cases: cefixime
  • Sexual partners in the last 60 days should be notified and tested
  • Drug-resistant gonorrhea is a growing public health concern
  • Retest 1 to 2 weeks after treatment to confirm cure
LGBTQ+ note: Gonorrhea rates are disproportionately high among gay and bisexual men. Throat and rectal infections are almost always asymptomatic and will be missed if only urine is tested. Always specify all sites of sexual contact when requesting testing.

Chlamydia Curable

Bacterial Infection (Chlamydia trachomatis)

Symptoms

  • Often none (up to 70% of cases)
  • Penile: mild discharge, burning urination
  • Vaginal/cervical: discharge, bleeding between periods, pelvic pain
  • Rectal: discharge, pain, bleeding
  • Untreated: can cause pelvic inflammatory disease (PID) and fertility issues in people with a uterus

Testing

  • Urine NAAT test (most common)
  • Swabs from urethra, cervix, rectum, or throat as appropriate
  • At-home test kits widely available through mail-order programs
  • CDC recommends annual testing for all sexually active women under 25
  • Every 3 to 6 months for sexually active MSM and trans people at risk

Treatment

  • Doxycycline (100mg twice daily for 7 days) is first-line treatment
  • Single-dose azithromycin is an alternative (less effective per newer data)
  • All partners in the last 60 days should be treated
  • Avoid sex for 7 days after single-dose or during full course treatment
  • Retest 3 months after treatment (reinfection is common)
LGBTQ+ note: LGV (Lymphogranuloma venereum) is a more aggressive chlamydia strain that is increasingly found in MSM communities, particularly among those who engage in receptive anal sex. It requires a longer doxycycline course (21 days) and testing for LGV specifically if you have rectal symptoms.

Syphilis Curable

Bacterial Infection (Treponema pallidum)

Symptoms by Stage

  • Primary: painless sore (chancre) at infection site, often goes unnoticed
  • Secondary: rash (often on palms and soles), flu-like symptoms, wart-like sores
  • Latent: no symptoms (can last years)
  • Tertiary: serious damage to heart, brain, and other organs (if untreated)
  • Neurosyphilis: can occur at any stage, causes neurological symptoms

Testing

  • Blood test (RPR or VDRL as initial screen; confirmed with treponemal test)
  • Swab of any active sore
  • CDC recommends annual syphilis testing for sexually active MSM
  • More frequent if multiple partners
  • Testing recommended during each prenatal visit

Treatment

  • Penicillin G injection: highly effective at all stages
  • Primary and secondary: single dose benzathine penicillin G IM
  • Latent or tertiary: multiple weekly injections
  • Doxycycline for penicillin-allergic patients
  • Follow-up blood tests at 6 and 12 months to confirm treatment success
LGBTQ+ note: Syphilis rates have increased dramatically among MSM over the past decade, with a record high in 2022. Syphilis chancres are often painless and may be hidden inside the rectum or on the cervix where they cannot be seen. Annual (or more frequent) testing is essential even if you feel completely well.

Herpes (HSV-1 and HSV-2) Manageable

Viral Infection (Herpes Simplex Virus)

Symptoms

  • Often none or very mild (most people don't know they have it)
  • Outbreaks: clusters of blisters or sores on or around genitals, buttocks, or mouth
  • First outbreak may include fever, body aches, swollen lymph nodes
  • Outbreaks tend to decrease in frequency and severity over time
  • Tingling or burning sensation before an outbreak (prodrome)

Testing

  • Swab of active sore is most accurate
  • Blood test (type-specific IgG) can detect infection without active sores
  • HSV-2 blood testing has false positive rates: discuss with provider
  • Standard STI panels often do not include herpes blood testing; ask specifically
  • Testing during an outbreak is most reliable

Treatment

  • No cure, but antiviral medications effectively control symptoms
  • Acyclovir, valacyclovir (Valtrex), or famciclovir reduce outbreak severity and duration
  • Daily suppressive therapy: reduces outbreaks by 70 to 80% and reduces asymptomatic shedding (reducing transmission risk)
  • People on suppressive therapy with no active sores can still transmit herpes; condoms further reduce risk
Context: HSV-1 (commonly associated with cold sores) can be transmitted genitally through oral sex. An estimated 67% of people under 50 globally have HSV-1. An estimated 11% of Americans have HSV-2. Having herpes does not define you or make you "dirty." Millions of people in healthy, loving relationships have herpes. Open communication with partners and suppressive therapy are the tools for managing it with care.

HPV (Human Papillomavirus) Vaccine-Preventable

Viral Infection (over 100 strains)

Symptoms

  • Most HPV infections: no symptoms and clear on their own
  • Some low-risk strains: genital warts (soft, flesh-colored growths)
  • High-risk strains (HPV-16, HPV-18): associated with cervical, anal, penile, oral, and throat cancers
  • Anal HPV: particularly relevant for MSM and anyone who has receptive anal sex
  • Cancer develops years to decades after initial infection

Testing and Screening

  • No approved HPV test for people with a penis; diagnosis by visual inspection or biopsy of lesions
  • Cervical HPV: tested during Pap smear (co-testing for people over 30)
  • Anal Pap smear: recommended for MSM and HIV-positive individuals to screen for anal cancer precursors; ask your provider
  • Anoscopy: visual exam of the anal canal; recommended if anal Pap is abnormal

Prevention and Treatment

  • Gardasil 9 vaccine: protects against 9 HPV strains including the highest-risk cancer-causing types. Approved for ages 9 to 45
  • CDC recommends vaccination for everyone through age 26. For ages 27 to 45, discuss with your provider
  • Genital warts: treated with topical medications, cryotherapy, or laser removal
  • No antiviral treatment for HPV itself; most infections clear within 1 to 2 years
LGBTQ+ note: MSM who have never been vaccinated have significantly higher rates of anal HPV infection and anal cancer. Anal cancer rates are rising in this population. If you are a gay or bisexual man and have not been vaccinated, talk to your provider about Gardasil 9 and whether anal Pap screening is appropriate for you.

Hepatitis A and B Vaccine-Preventable

Viral Liver Infections

Transmission

  • Hep A: fecal-oral route; transmitted through rimming (oral-anal contact), contaminated food/water
  • Hep B: blood, semen, vaginal fluids; transmitted through sex, needle sharing, and from parent to child at birth
  • Hep C: primarily blood-to-blood; less efficiently through sex (more relevant with anal sex involving blood, HIV co-infection, or injection drug use)

Testing

  • Blood tests for Hepatitis A antibodies, Hepatitis B surface antigen/antibody, and Hepatitis C antibody
  • All sexually active adults should know their Hep B status
  • Hep C test recommended at least once for all adults
  • More frequent Hep C testing for people who inject drugs or have multiple partners

Prevention and Treatment

  • Hepatitis A vaccine: 2-dose series, highly effective
  • Hepatitis B vaccine: 3-dose series (or 2-dose Heplisav-B), highly effective
  • Both vaccines recommended for all LGBTQ+ adults who are not immune
  • Hepatitis C: curable with modern direct-acting antivirals (DAAs) taken for 8 to 12 weeks with very high cure rates
Note on Truvada/Descovy and Hepatitis B: Both medications used in PrEP treat Hepatitis B in addition to preventing HIV. If you have Hepatitis B and start or stop PrEP, this can significantly affect your Hepatitis B status. Always tell your provider if you have Hepatitis B before starting or stopping these medications.

Mpox (formerly Monkeypox) Vaccine Available

Viral Infection (Orthopoxvirus)

Symptoms

  • Rash or sores that look like pimples or blisters, which may appear on genitals, rectum, hands, feet, chest, face, or mouth
  • Flu-like symptoms: fever, swollen lymph nodes, fatigue, body aches
  • Rectal pain or discharge if rectal lesions are present
  • Symptoms appear 3 to 17 days after exposure
  • Illness typically lasts 2 to 4 weeks

Transmission and Testing

  • Close skin-to-skin contact with rash, sores, or scabs
  • Contact with infected respiratory secretions during prolonged face-to-face contact
  • Contact with contaminated materials (bedding, clothing)
  • Testing: swab from active lesion, sent to lab; requires provider order
  • Tell your provider if you have a new unexplained rash

Prevention and Treatment

  • JYNNEOS vaccine: two-dose series, highly effective at preventing mpox
  • Recommended for gay/bisexual men and trans people who are sexually active
  • Vaccine available through health departments, LGBTQ+ health centers, and some providers
  • Tecovirimat (TPOXX): antiviral treatment for severe cases
  • Most cases resolve on their own; treatment focuses on symptom management
LGBTQ+ note: During the 2022 global mpox outbreak, gay and bisexual men and other MSM were disproportionately affected due to skin-to-skin sexual contact being a primary transmission route. If you are sexually active and have not been vaccinated, contact your local health department or LGBTQ+ health center about JYNNEOS vaccination.

How Often Should You Get Tested?

Gay and Bisexual Men (MSM)

  • HIV: every 3 to 6 months if sexually active
  • Gonorrhea and chlamydia (all sites): every 3 months
  • Syphilis: every 3 to 6 months
  • Hepatitis B and C: annually if not immune
  • HPV: Gardasil 9 vaccine if not previously vaccinated; discuss anal Pap with provider
CDC Sexual Health Recommendations

Transgender and Non-Binary People

  • Test based on anatomy and behaviors, not gender identity
  • HIV: every 3 to 6 months if at risk
  • Bacterial STIs from sites of sexual activity: every 3 months if sexually active
  • Cervical Pap: every 3 years (if cervix present), even on testosterone
  • Testicular exam: if testes still present
Anatomy-based, not identity-based testing

Lesbians and Bisexual Women

  • STIs can be transmitted between women and non-binary AFAB people through shared sex toys, skin contact, and oral sex
  • Bacterial vaginosis: more common in women who have sex with women
  • HPV: transmitted through skin contact; Pap smears on normal schedule
  • HIV: lower risk but not zero, especially with trans or male partners; test annually if sexually active
  • Full STI panel annually or as recommended by provider
Based on sexual practices

Where to Get Tested Free or Low-Cost

  • Planned Parenthood: STI testing, often low-cost with sliding scale
  • Local health departments: free STI testing, walk-in often available
  • LGBTQ+ health centers: comprehensive panels, affirming staff
  • CDC GetTested.cdc.gov: zip code finder for free testing near you
  • At-home test kits: available through mail programs including USPS home test programs
gettested.cdc.gov
Doxy-PEP: A New STI Prevention Strategy

Doxycycline post-exposure prophylaxis (doxy-PEP) is a newer approach where taking a single dose of doxycycline within 72 hours of a sexual encounter significantly reduces the risk of bacterial STIs. A 2022 study published in the New England Journal of Medicine (ANRS Doxy-PEP trial) found doxycycline reduced gonorrhea, chlamydia, and syphilis infections by approximately 65% in MSM and trans women when used as directed. The CDC released updated guidelines for doxy-PEP in 2023. Ask your provider whether doxy-PEP is appropriate for you.

  • CDC. Sexually Transmitted Infections Surveillance, 2022. cdc.gov/std
  • CDC. STI Treatment Guidelines, 2021. cdc.gov/std/treatment-guidelines
  • WHO. Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2021.
  • Luetkemeyer AF, et al. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. N Engl J Med. 2023;388:1296-1306. (ANRS Doxy-PEP)
  • CDC. Updated Guidelines on Doxycycline Postexposure Prophylaxis (Doxy-PEP). 2023.
  • USPSTF. Cervical Cancer Screening Recommendation. JAMA. 2018;320(7):674-686.
  • CDC. Hepatitis A, B, and C Vaccination Recommendations. cdc.gov/hepatitis
  • CDC. HPV Vaccination Schedule and Requirements. cdc.gov/vaccines/vpd/hpv
Stay Connected

Community news, new resources, and LGBTQ+ updates. No spam. Unsubscribe anytime.